Discover results-proven tools and methodologies for your clinical development. Learn how to improve your trial design, data collection and clinical supply. In addition, get key information on how to improve your patient recruitment and retention. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in clinical development to exchange ideas on best practice and share case studies on innovation within the area.

Global Clinical Trial Opportunities in Japan (1)

Contributor: Mohamed Oubihi
Posted: 1/7/2014

Global Clinical Trial Opportunities in Japan (1) - Mohamed Oubihi

Since 2007, Japan has been engaged in a sweeping wave of reforms covering the pharmaceutical regulatory environment and the clinical trial infrastructure in order to enable a swift execution of global clinical trials in Japan and eradicate the onerous “drug lag problem” ie delay between launch of a drug in the West (EU/US) and Japan. This first article is an introduction to some unique features of Japanese clinical trial environment and the changes that have been ongoing in the past few years. Full Article »

Events related to this topic:

Experiences with IRT- An Interview with CTS manager Michael Pompey

Contributor: Michael Pompey
Posted: 10/22/2013

Experiences with IRT- An Interview with CTS manager Michael Pompey - Michael Pompey

Ahead of the Clinical Trial Supply Europe event, Pharma IQ presents interviews filmed live at last year's CTS event. In this interview Michael Pompey talks about the daily challenges he faces as a clinical trial supply manager at Sandoz and he discusses his experience with IRT. Full Video »

Events related to this topic:

Epigenetic Cancer Therapies and the TOPAS Trial- An Interview with Hella Kohlhof - Gerald Clarke

For Dr Hella Kohlhof, the study of epigenetics was not love at first sight, however the potential it posesses eventually won her over. Now Dr Kohlhof is Manager of Translational Pharmacology at 4SC AG and is applying epigenetic knowledge in a phase 1 first-in-man trial. She talks to us about what role epigentics plays in cancer and how new therapies are taking advantage of epigenetic mechanisms. Full Podcast »

Events related to this topic:

Adapting to Disruptive Change in the Pharmaceutical Industry

Contributor: Andrew Parsons
Posted: 4/8/2013

Adapting to Disruptive Change in the Pharmaceutical Industry - Andrew Parsons

The Pharmaceutical Industry continues to change at what feels like an exponential pace. What used to be a stable industry now faces almost continual re-shaping as the life cycle of R&D and commercialisation adapts to new players and shapers. New Pharma IQ columnist, Andrew Parsons explains. Full Column »

Events related to this topic:

Factors Influencing Clinical Trial Site Selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)

The SAT-EU study group, an independent non-profit collaborative initiative, supported by the European Forum for Good Clinical Practice (EFGCP) and several other trade and not-for profit organisations, release the results of a survey of 458 professionals representing clinical research organizations (CROs), academic clinical trial units (CTUs), and the biopharmaceutical industry in 34 countries. Full Whitepaper »

Events related to this topic:

Advertise With Us

Join the Pharmas IQ Community